
Our business allocation model has been proven to lead to process efficiencies through effective cost, relationship, and process management alignment strategies.

A new age of diagnostic testing is evolving that utilizes patient test result information to customize and guide therapy. Pharmaceutical companies are seeking partners to develop and commercialize new diagnostic tests. Our expertise in the identification, optimization and validation of biomarker assays for all phases of drug development and clinical diagnostic applications, makes Quest Diagnostics an ideal partner for pharmaceutical and biotechnology companies and clinical diagnostic test providers.
Quest, Quest Diagnostics, the associated logo, Nichols Institute and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics.
All third-party marks- ® - are the property of their respective owners. © 2000-2010 Quest Diagnostics Incorporated. All rights reserved.